pulmonary-fibrosis

Documents about pulmonary-fibrosis

• Targeting alveolar type II cell dysfunction in idiopathic pulmonary fibrosis: Molecular mechanisms and emerging therapeutic strategies (Review).#388730NCBI PubMed Central
• Integrated Approaches in Drug Repositioning Highlight Ouabain and Helenalin as Potential Drug Candidates for Pulmonary Fibrosis.#446103NCBI PubMed Central
• Real-World Economic Burden Associated with Progressive Pulmonary Fibrosis in the US: An Administrative Claims Database Analysis.#483470NCBI PubMed Central
• Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study#680738Spiral
• Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis#886392ClinicalTrials.gov
• Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects#911418ClinicalTrials.gov
• Validation of the C-mo System - Cough Monitoring#813097ClinicalTrials.gov
• Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosis.#13516NCBI PubMed Central
• Bidirectional fibrogenic cross-talk revealed in a human iPSC-derived epithelial-mesenchymal co-culture model of pulmonary fibrosis#283946Europe PMC
• Caring for Rural Patients With Interstitial Lung Disease: Perspectives of Pulmonary Fibrosis Foundation Care Center Network Nurses and Providers.#427751NCBI PubMed Central
• Explainable pulmonary fibrosis detection using edge-strengthened dilated holistic edge detection-based lung segmentation and ResNet-V2 classification.#430790NCBI PubMed Central
• Pleuroparenchymal fibroelastosis in rheumatoid arthritis-associated interstitial lung disease#450669S-Space: Seoul National University
• University of Virginia Natural History Study#804619ClinicalTrials.gov
• RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients#893830ClinicalTrials.gov
• Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers#993701ClinicalTrials.gov
• Skeletal Muscle Function in Interstitial Lung Disease#1029803ClinicalTrials.gov
• LBM & Lung Function in Adolescents With CF#1046936ClinicalTrials.gov
• Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context#897977ClinicalTrials.gov
• Antagonistic Effect of Erythropoietin Receptor Signaling in Macrophages and Type II Alveolar Epithelial Cells on Pulmonary Fibrosis in Mice.#154282NCBI PubMed Central
• Targeting cuproptosis: a potential new therapeutic strategy for idiopathic pulmonary fibrosis#374097Figshare
• Exposure-informed lung transcriptomic analysis links predicted NNK targets to cell type-specific remodeling programs in idiopathic pulmonary fibrosis.#420996NCBI PubMed Central
• Exploring the views of people living with pulmonary fibrosis and health professionals on genetic testing in PF: A qualitative study#640147bioRxiv / medRxiv
• Effects of Home-based Inspiratory Muscle Training in Patients With IPF#848540ClinicalTrials.gov
• Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases#878928ClinicalTrials.gov
• A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects#885898ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects#1009679ClinicalTrials.gov
• An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE#860361ClinicalTrials.gov
• Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease#1046822ClinicalTrials.gov
• Global burden, trends and projections analysis of interstitial lung disease and pulmonary sarcoidosis in elderly adults (aged 55+ Years) based on GBD 2021#120213PLOS
• Biomarkers of mitochondrial dynamics in idiopathic pulmonary fibrosis: Identification and validation through transcriptomic and single-cell analyses#130386Unpaywall
• Integrative multi-omics analysis reveals microbiota alterations and clinical indicators predictive of pulmonary fibrosis progression following SARS-CoV-2 infection.#148187NCBI PubMed Central
• Combined mesenchymal stem cells and metformin therapy modulates key macromolecular pathways in pulmonary fibrosis based on evidence from untargeted metabolomics.#165608NCBI PubMed Central
• Using SFTPC and computed tomographic volumetric imaging to diagnose and predict outcomes in usual interstitial pneumonia-type idiopathic pulmonary fibrosis.#258181NCBI PubMed Central
• A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD#441993ClinicalTrials.gov
• To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers#893837ClinicalTrials.gov
• Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest#1031720ClinicalTrials.gov
• Biomarkers of mitochondrial dynamics in idiopathic pulmonary fibrosis: Identification and validation through transcriptomic and single-cell analyses#126098PLOS
• The Relationship Between Pulmonary Spiculation and Central Fibrosis, Along With Other Clinicopathological Features, in Invasive Lung Adenocarcinoma and Its Prognostic Significance.#265343NCBI PubMed Central
• Erratum : Pirfenidone for idiopathic pulmonary fibrosis: A systematic review and meta-analysis (PLoS ONE 10:8 (e0136160) 10.1371/journal.pone.0136160)#277485Repositorio USS
• Toward Self-management in ILD#857222ClinicalTrials.gov
• The Occurence of Inflammation and Oxidative Stress in Lung Diseases#871393ClinicalTrials.gov
• Remote Monitoring of High-Risk Patients With Chronic Cardiopulmonary Diseases#910049ClinicalTrials.gov
• Advancing Symptom Alleviation With Palliative Treatment#969663ClinicalTrials.gov
• Integrated Serum Pharmacochemistry, Network Pharmacology, and Transcriptomics Reveal the Mechanisms and Active Constituents of Qingfei Huoxue Decoction Against Bleomycin-Induced Pulmonary Fibrosis.#4061NCBI PubMed Central
• Kangxianhuanji formula and its component rutin ameliorate acute exacerbation of idiopathic pulmonary fibrosis by targeting GLUT1 to suppress HIF-1α-mediated glycolysis.#172106NCBI PubMed Central
• Physiopathologie des pneumopathies interstitielles diffuses pédiatriques d'origine génétique ou supposée génétique#229816HAL (France)
• Baby Observational and Nutritional Study#841049ClinicalTrials.gov
• Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects#904830ClinicalTrials.gov
• Fibered Confocal Fluorescence Microscopy Imaging in Patients With Diffuse Parenchymal Lung Diseases#1045032ClinicalTrials.gov
• COVID-19 Pathophysiology of Long Term Implications#1045151ClinicalTrials.gov